Quadruplets are now standard upfront for transplant patients, dual maintenance is expanding, MRD is guiding transplant needs, and high-risk patients benefit from continuous aggressive therapy. #AsktheIMF
August 18, 2025 at 11:10 PM
Quadruplets are now standard upfront for transplant patients, dual maintenance is expanding, MRD is guiding transplant needs, and high-risk patients benefit from continuous aggressive therapy. #AsktheIMF
How can older myeloma patients decide what treatment is still worth pursuing? IMF NLB member Sam Shenoy answers and points to the IMF's free Decision-Making Tool at myeloma.org.
#AsktheIMF #KnowMyeloma #mmsm
#AsktheIMF #KnowMyeloma #mmsm
September 22, 2026 at 8:03 PM
How can older myeloma patients decide what treatment is still worth pursuing? IMF NLB member Sam Shenoy answers and points to the IMF's free Decision-Making Tool at myeloma.org.
#AsktheIMF #KnowMyeloma #mmsm
#AsktheIMF #KnowMyeloma #mmsm
You’ve got questions, and IMF Chief Medical Officer @jmikhaelmd.bsky.social has answers! Join us LIVE on Facebook on Saturday, July 19 at 10:15am PST to ask Dr. Joe anything about myeloma. RSVP now at https://www.facebook.com/events/1196152482539505
#AsktheIMF #mmsm
#AsktheIMF #mmsm
July 13, 2025 at 6:01 PM
You’ve got questions, and IMF Chief Medical Officer @jmikhaelmd.bsky.social has answers! Join us LIVE on Facebook on Saturday, July 19 at 10:15am PST to ask Dr. Joe anything about myeloma. RSVP now at https://www.facebook.com/events/1196152482539505
#AsktheIMF #mmsm
#AsktheIMF #mmsm
Unfortunately, we don't really know the cause of multiple myeloma in most patients. Tune in for the full Q&A video with International Myeloma Foundation Chief Medical Officer Dr. Joseph Mikhael at https://www.myeloma.org/node/11783 & tag #AsktheIMF on social to submit your questions!
July 15, 2025 at 12:54 PM
Unfortunately, we don't really know the cause of multiple myeloma in most patients. Tune in for the full Q&A video with International Myeloma Foundation Chief Medical Officer Dr. Joseph Mikhael at https://www.myeloma.org/node/11783 & tag #AsktheIMF on social to submit your questions!
Late relapse multiple myeloma: Could a one-time CAR T-cell treatment keep myeloma away for 5 years? Dr. Joseph Mikhael shares ASCO/EHA 2025 breakthroughs changing myeloma care. Watch now: https://mmsm.link/45E9isx #AsktheIMF
August 18, 2025 at 12:02 AM
Late relapse multiple myeloma: Could a one-time CAR T-cell treatment keep myeloma away for 5 years? Dr. Joseph Mikhael shares ASCO/EHA 2025 breakthroughs changing myeloma care. Watch now: https://mmsm.link/45E9isx #AsktheIMF
IMF Chief Medical Officer Dr. Joseph Mikhael shares the highlights of the 2025 International Myeloma Society meeting in this new video. See his full thoughts on the research from this important meeting at https://www.myeloma.org/node/12174 #AsktheIMF
October 24, 2025 at 8:03 PM
IMF Chief Medical Officer Dr. Joseph Mikhael shares the highlights of the 2025 International Myeloma Society meeting in this new video. See his full thoughts on the research from this important meeting at https://www.myeloma.org/node/12174 #AsktheIMF
"One challenge with this drug is some eye-related side effects like blurry vision. But giving it less frequently lowers this risk. Many patients, especially those not eligible for CAR T, could benefit from Blenrep (belantamab mafodotin) given every 8 to 12 weeks."
#AskTheIMF
#AskTheIMF
August 21, 2025 at 6:32 PM
"One challenge with this drug is some eye-related side effects like blurry vision. But giving it less frequently lowers this risk. Many patients, especially those not eligible for CAR T, could benefit from Blenrep (belantamab mafodotin) given every 8 to 12 weeks."
#AskTheIMF
#AskTheIMF
Don't hesitate to reach out to the IMF. We are here for you! Join IMF Chief Medical Officer Dr. Joe on Monday, Sept. 8 for a live Q&A to get your questions answered. RSVP now, hit "Going" at https://www.facebook.com/events/3757713881192843/permalink/3757713901192841 #AsktheIMF #mmsm
August 29, 2025 at 3:19 PM
Don't hesitate to reach out to the IMF. We are here for you! Join IMF Chief Medical Officer Dr. Joe on Monday, Sept. 8 for a live Q&A to get your questions answered. RSVP now, hit "Going" at https://www.facebook.com/events/3757713881192843/permalink/3757713901192841 #AsktheIMF #mmsm
SARCLISA (isatuximab) is being studied with an on-body injector that delivers the drug subcutaneously over 12-15 minutes—no IV needed. A promising new way to make treatment more convenient! #AskTheIMF
August 23, 2025 at 2:25 PM
SARCLISA (isatuximab) is being studied with an on-body injector that delivers the drug subcutaneously over 12-15 minutes—no IV needed. A promising new way to make treatment more convenient! #AskTheIMF
"What are the long-term side effects of myeloma treatment?"
Dr. Joe answers the question.
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
Dr. Joe answers the question.
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
October 13, 2025 at 2:33 PM
"What are the long-term side effects of myeloma treatment?"
Dr. Joe answers the question.
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
Dr. Joe answers the question.
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
From #ASH25: We break down the 10 most impactful myeloma breakthroughs, including advances in CAR T-cell therapy and bispecific antibodies and what this latest research means for people living with myeloma. Watch now: mmsm.link/4qeZrlU
#IMFASH25 #ASKTHEIMF
@jmikhaelmd.bsky.social
#IMFASH25 #ASKTHEIMF
@jmikhaelmd.bsky.social
January 8, 2026 at 11:28 PM
From #ASH25: We break down the 10 most impactful myeloma breakthroughs, including advances in CAR T-cell therapy and bispecific antibodies and what this latest research means for people living with myeloma. Watch now: mmsm.link/4qeZrlU
#IMFASH25 #ASKTHEIMF
@jmikhaelmd.bsky.social
#IMFASH25 #ASKTHEIMF
@jmikhaelmd.bsky.social
What questions should you ask your doctor after a myeloma relapse? Dr. Joseph Mikhael, IMF Chief Medical Officer, gives helpful advice and answers other questions on relapsed myeloma in this new video. Watch the full thing now at https://www.myeloma.org/node/11799 #AsktheIMF
July 27, 2025 at 12:01 PM
What questions should you ask your doctor after a myeloma relapse? Dr. Joseph Mikhael, IMF Chief Medical Officer, gives helpful advice and answers other questions on relapsed myeloma in this new video. Watch the full thing now at https://www.myeloma.org/node/11799 #AsktheIMF
"Am I at higher risk if my mother and half-sister both had multiple myeloma?"
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455. Dr. Joe answers the question:
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455. Dr. Joe answers the question:
October 5, 2025 at 11:00 PM
"Am I at higher risk if my mother and half-sister both had multiple myeloma?"
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455. Dr. Joe answers the question:
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455. Dr. Joe answers the question:
IMF Chief Medical Officer Dr. Joseph Mikhael discusses the latest updates from the 2025 International Myeloma Society (IMS) meeting on high risk multiple myeloma (HRMM). See his extended thoughts on the IMS meeting research at https://www.myeloma.org/node/12174 #AsktheIMF
October 26, 2025 at 5:01 PM
IMF Chief Medical Officer Dr. Joseph Mikhael discusses the latest updates from the 2025 International Myeloma Society (IMS) meeting on high risk multiple myeloma (HRMM). See his extended thoughts on the IMS meeting research at https://www.myeloma.org/node/12174 #AsktheIMF
Multiple myeloma research is moving fast. Dr. Joseph Mikhael breaks down key ASCO and EHA 2026 findings on bispecifics, CELMoDs, belantamab, and in vivo CAR T—and what they could mean for patients and families. Watch now 👉 https://mmsm.link/4f7GQUv
#AsktheIMF #mmsm #cartcelltherapy
#AsktheIMF #mmsm #cartcelltherapy
July 10, 2026 at 2:09 PM
Multiple myeloma research is moving fast. Dr. Joseph Mikhael breaks down key ASCO and EHA 2026 findings on bispecifics, CELMoDs, belantamab, and in vivo CAR T—and what they could mean for patients and families. Watch now 👉 https://mmsm.link/4f7GQUv
#AsktheIMF #mmsm #cartcelltherapy
#AsktheIMF #mmsm #cartcelltherapy
Myeloma community, we want to see you live on 12/8! IMF Chief Medical Officer Dr. Joseph Mikhael & support group leaders will be live at ASH sharing what’s important in myeloma from the latest ASH research. Hit "Going": https://www.facebook.com/events/837237505620824
#AsktheIMF
#ASH25
#IMFASH25
#AsktheIMF
#ASH25
#IMFASH25
November 16, 2025 at 12:19 AM
Myeloma community, we want to see you live on 12/8! IMF Chief Medical Officer Dr. Joseph Mikhael & support group leaders will be live at ASH sharing what’s important in myeloma from the latest ASH research. Hit "Going": https://www.facebook.com/events/837237505620824
#AsktheIMF
#ASH25
#IMFASH25
#AsktheIMF
#ASH25
#IMFASH25
A common definition of cure in myeloma could apply to all patients alike — using blood, bone marrow, and imaging tests to confirm lasting remission.
#MyelomaCure #AsktheIMF
#MyelomaCure #AsktheIMF
May 15, 2026 at 2:21 PM
A common definition of cure in myeloma could apply to all patients alike — using blood, bone marrow, and imaging tests to confirm lasting remission.
#MyelomaCure #AsktheIMF
#MyelomaCure #AsktheIMF
Could pesticides, chemicals, or military toxins contribute to myeloma? Dr. Joseph Mikhael answers in this short video. Watch the full Q&A at https://www.myeloma.org/node/12840
#AsktheIMF
#AsktheIMF
April 1, 2026 at 6:00 PM
Could pesticides, chemicals, or military toxins contribute to myeloma? Dr. Joseph Mikhael answers in this short video. Watch the full Q&A at https://www.myeloma.org/node/12840
#AsktheIMF
#AsktheIMF
Dr. Joe answers the question: "What do #myeloma patients do when they're allergic to steroids?"
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
October 6, 2025 at 2:15 PM
Dr. Joe answers the question: "What do #myeloma patients do when they're allergic to steroids?"
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
Dr. Joe answers the question: "Can new treatments get approved faster?"
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
October 15, 2025 at 7:22 PM
Dr. Joe answers the question: "Can new treatments get approved faster?"
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
Ask your questions using #AsktheIMF or contact our InfoLine for personalized support at 1-818-487-7455.
In early relapse, patients have more treatment options than ever—whether antibody drug conjugates, or bispecific antibodies These advances, alongside CAR T-cell therapy and triplets, offer richer choices for care. #AskTheIMF
August 25, 2025 at 7:30 PM
In early relapse, patients have more treatment options than ever—whether antibody drug conjugates, or bispecific antibodies These advances, alongside CAR T-cell therapy and triplets, offer richer choices for care. #AskTheIMF
Can treatment decisions now limit your options later? The IMF's Dr. Joseph Mikhael explains. Learn more about myeloma treatment decisions today on the IMF YouTube channel. https://www.youtube.com/@IMFMyeloma
#AsktheIMF #mmsm
#AsktheIMF #mmsm
June 12, 2026 at 2:53 PM
Can treatment decisions now limit your options later? The IMF's Dr. Joseph Mikhael explains. Learn more about myeloma treatment decisions today on the IMF YouTube channel. https://www.youtube.com/@IMFMyeloma
#AsktheIMF #mmsm
#AsktheIMF #mmsm
Can bone destruction begin silently during MGUS? Can that pathway be interrupted? Myeloma expert Dr. Joseph Mikhael answers in this short video. Watch the experts answer your myeloma questions in the full Q&A at https://www.myeloma.org/node/12840
#AsktheIMF
#AsktheIMF
April 4, 2026 at 1:34 PM
Can bone destruction begin silently during MGUS? Can that pathway be interrupted? Myeloma expert Dr. Joseph Mikhael answers in this short video. Watch the experts answer your myeloma questions in the full Q&A at https://www.myeloma.org/node/12840
#AsktheIMF
#AsktheIMF
In this Q&A, Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, answers real questions from patients and families about smoldering #myeloma, double-hit progression, supplements, and neurological complications. https://www.myeloma.org/node/12071
#AskTheIMF
#AskTheIMF
August 21, 2025 at 2:07 PM
In this Q&A, Dr. Joseph Mikhael, Chief Medical Officer of the International Myeloma Foundation, answers real questions from patients and families about smoldering #myeloma, double-hit progression, supplements, and neurological complications. https://www.myeloma.org/node/12071
#AskTheIMF
#AskTheIMF
IMF Chief Medical Officer Dr. Joseph Mikhael shares the latest lessons on myeloma treatment shared at the 2025 International Myeloma Society (IMS) meeting. Follow along with his thoughts on the meeting at https://www.myeloma.org/node/12174 #AsktheIMF
October 27, 2025 at 2:20 PM
IMF Chief Medical Officer Dr. Joseph Mikhael shares the latest lessons on myeloma treatment shared at the 2025 International Myeloma Society (IMS) meeting. Follow along with his thoughts on the meeting at https://www.myeloma.org/node/12174 #AsktheIMF